Skydance
SKYD
$7.90
-1.74%
Skydance Corporation is a diversified media and entertainment conglomerate operating across three segments: TV media (CBS, 15 owned affiliates, CNN, TBS, TNT, Nickelodeon, MTV, BET, VH1), filmed entertainment (Warner Bros., HBO, and Paramount Pictures), and direct-to-consumer streaming (HBO Max, Paramount+, Pluto TV, BET+). Formed through the combination of Skydance, Paramount, and Warner Bros. Discovery assets, the company is a scaled legacy-media platform with a portfolio spanning broadcast, cable, premium film, and streaming — a positioning that makes it one of the largest content owners in the industry but also one of the most exposed to cord-cutting and linear advertising erosion. The investor narrative is dominated by the integration and deleveraging story: the market is debating whether management can realize merger synergies, stabilize linear cash flows, and turn the streaming portfolio profitable fast enough to offset a heavily leveraged balance sheet and a deeply negative trailing earnings profile. Recent trading has been volatile and negative, with the stock down sharply over the past month and underperforming the S&P 500, reflecting skepticism about execution risk, a wave of cautious sell-side initiations (UBS, Barclays, Wells Fargo, Bernstein all at Sell/Underweight), and the absence of a clear near-term catalyst.…
SKYD
Skydance
$7.90
Investment Opinion: Should I buy SKYD Today?
Rating: Hold (cautious, evidence-weighted). The core thesis is that SKYD is a statistically cheap but operationally unproven legacy-media roll-up trading at 0.51x sales against a historical PS range of 1.59x–3.10x, where the entire investment case hinges on whether the Q2 2026 gross-margin collapse to 6.87% was a transitional merger-accounting event or structural erosion. With only five analysts covering the name and a ratings mix spanning StoneX and Benchmark at Buy, Morgan Stanley at Overweight, Citizens at Market Outperform, JP Morgan and TD Cowen at Neutral/Hold, and UBS, Barclays, Wells Fargo and Bernstein at Sell/Underweight/Underperform, the sell-side is genuinely split rather than consensus-bearish, which argues against an outright Sell at $8.01 after an 18% bounce off the 6.80 low.
Supporting evidence for holding rather than selling: the stock trades at 0.51x PS versus its own 1.59x Q2 2026 and 3.10x Q3 2025 readings (an 84% discount to peak), 1.27x price-to-book, and roughly 9.0x the consensus 2026 EPS of $0.8925 (tight $0.865–$0.927 range) — implying the Street expects a swing from trailing -$0.42 EPS to profitability. Free cash flow is positive at $440 million TTM, including $258 million in Q2 2026 on just $61 million of capex, and the $56 million quarterly dividend (0.61% yield) is still being paid. Offsetting this, revenue grew only 0.93% year-over-year to $6.913 billion, trailing net margin is -21.2%, ROE is -52.9%, and price-to-free-cash-flow of 30.6x shows the stock is not cheap on cash generation despite the sales discount.
Biggest risks that could invalidate the Hold: (1) the 6.87% Q2 2026 gross margin proves structural, making the $0.8925 forward EPS unachievable and forcing consensus cuts; (2) interest coverage of roughly 1.86x ($255 million interest expense versus $215 million pre-tax income) with 1.27x debt-to-equity and cash falling to $1.627 billion from $1.941 billion forces a dividend suspension or equity raise; (3) continued linear affiliate ($3.520 billion) and advertising ($1.959 billion) erosion outpaces streaming profitability. This Hold would upgrade to Buy if a clean quarter shows gross margin recovering toward the 33.9% Q1 2026 level alongside positive net income, or if PS stays below 0.6x while FCF holds above $400 million; it would downgrade to Sell on a break below the 6.80 low or a cut to the 2026 EPS consensus. Verdict: cheap on sales and book, expensive on cash flow, uninvestable on trailing earnings — fairly valued only if the turnaround materializes, otherwise a value trap.
Sign up to view all
SKYD 12-Month Price Forecast
The forward view is genuinely two-sided: the stock is statistically cheap at 0.51x sales and 1.27x book, and the Street's tight $0.865–$0.927 EPS band signals conviction in a profitability swing that would put shares on roughly 9.0x forward earnings. But revenue growth of just 0.93% year-over-year, a -21.2% trailing net margin, and the Q2 2026 gross-margin collapse to 6.87% mean the turnaround is entirely unproven, and the 30.6x price-to-free-cash-flow shows the cash-flow base is thin. Analyst sentiment is split rather than uniformly negative — two Buys, one Overweight, one Market Outperform, two Neutral/Hold, and four Sell/Underweight — with JP Morgan's October upgrade to Neutral suggesting the bear case is largely priced. I would upgrade to bullish on a clean quarter showing gross margin back above 30% with positive net income, or on a decisive break above the 9.53 October high; I would downgrade to bearish on a break below the 6.80 low or any cut to the 2026 EPS consensus.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Skydance's 12-month outlook, with a consensus price target around $9.06 and implied upside of +14.7% versus the current price.
Average Target
$9.06
24 analysts
Implied Upside
+14.7%
vs. current price
Analyst Count
24
covering this stock
Price Range
$4 - $14
Analyst target range
Five analysts cover SKYD, and the sentiment is mixed-to-cautious: the distribution includes two Buy-equivalent ratings (StoneX at Buy, Benchmark at Buy), one Overweight (Morgan Stanley), one Market Outperform (Citizens), and a cluster of negative views (UBS at Sell, Barclays and Wells Fargo at Underweight, Bernstein at Underperform), with JP Morgan recently upgrading to Neutral from Underweight on 2026-10-23 and TD Cowen at Hold. The consensus estimated EPS average of $0.8925 (range $0.86491 to $0.92686) and estimated revenue average of $33.91 billion (range $33.11 billion to $34.92 billion) imply the Street expects a dramatic earnings recovery from the current -$0.42 trailing EPS. Specific price targets are not provided in the data, so implied upside cannot be calculated; however, the recent JP Morgan upgrade from Underweight to Neutral is a modest positive signal that the negative case may be fully priced.
The target range for EPS is remarkably tight — $0.865 to $0.927, a spread of just 7% — which signals strong conviction in the near-term earnings estimate but says nothing about the wide dispersion in ratings (from Sell to Buy). The high end of the EPS range assumes successful merger integration, margin recovery toward the 33%+ gross margin seen in Q1 2026, and stabilization of linear cash flows; the low end likely bakes in continued gross-margin compression (as seen in Q2 2026's 6.9%) and integration costs. The pattern of institutional ratings shows a clear negative tilt established in August 2026 (UBS Sell, TD Cowen Hold, Benchmark Buy) with only one upgrade since (JP Morgan to Neutral), suggesting analysts are not yet willing to turn constructive. With only five analysts and no price targets disclosed, coverage is thin for a $14.8 billion market-cap company, which implies limited institutional sponsorship, higher volatility, and less efficient price discovery — consistent with the 24% single-day gap observed in October.
Bulls vs Bears: SKYD Investment Factors
The bear case currently holds stronger evidence: revenue is flat at +0.93% year-over-year, gross margin collapsed to 6.87% in Q2 2026, trailing EPS is -$0.42 with a -21.2% net margin, and the stock has underperformed the S&P 500 by 4.91 points in a month while four major brokers rate it Sell/Underweight. The bull case rests almost entirely on valuation — 0.51x sales versus a historical 1.59x–3.10x range — and on the Street's $0.8925 forward EPS, which implies roughly 9.0x forward earnings if the turnaround materializes. The single most important tension is whether the Q2 2026 gross-margin collapse to 6.87% was a one-off merger-accounting event or the start of structural margin erosion; if margins normalize back toward the 33%+ seen in Q1 2026, the forward earnings case is credible and the stock is deeply undervalued, but if 6.9% proves structural, the forward EPS estimate is unachievable and the value-trap read is correct. Until there is a clean quarter demonstrating margin recovery and positive net income, the evidence-weighted stance is cautious.
Bullish
- Deep discount to sales and book: SKYD trades at just 0.51x price-to-sales and 1.27x price-to-book, versus a historical PS range of 1.59x in Q2 2026 and 3.10x in Q3 2025 — an 84% discount to the prior peak multiple. On a $33.9 billion estimated 2026 revenue base, a sub-0.6x sales multiple prices in substantial value destruction for a company that owns CBS, CNN, Warner Bros., HBO and Paramount Pictures.
- Street expects swing to profitability: Consensus 2026 EPS of $0.8925 (tight range of $0.865–$0.927) implies a dramatic recovery from the trailing -$0.42 EPS, which at $8.01 equates to roughly 9.0x forward earnings. The 7% spread across analyst EPS estimates signals unusually high conviction in the near-term earnings trajectory.
- Positive free cash flow despite losses: SKYD generated $440 million of trailing free cash flow, including $258 million in Q2 2026 against only $61 million of capex, even while reporting a $41 million net loss. This cash generation is the resource that funds deleveraging and supports the $56 million quarterly dividend.
- JP Morgan upgrade signals negative case priced: JP Morgan upgraded SKYD to Neutral from Underweight on 2026-10-23, and the stock has since recovered from its 6.80 low to 8.01 — roughly 18% off the bottom. With two Buy ratings (StoneX, Benchmark) and one Overweight (Morgan Stanley) among five-to-nine covering analysts, the sell-side is not uniformly bearish.
Bearish
- Gross margin collapse to 6.9%: Q2 2026 gross margin fell to 6.87% ($475 million gross profit on $6.913 billion revenue) from 33.9% in Q1 2026 and 32.5% in Q2 2025 — a roughly 26-point year-over-year compression. This collapse, likely reflecting merger accounting, content write-downs or restructuring charges, makes the earnings base impossible to underwrite.
- Catastrophic Q4 2025 loss and negative EBITDA: Q4 2025 delivered a -$573 million net loss (EPS -$0.52) and a -$6.522 billion EBITDA driven by an $8.297 billion other-expense line, producing trailing net margin of -21.2%, operating margin of -18.0% and ROE of -52.9%. The EV/EBITDA of -5.36x is unusable because of this loss.
- Flat revenue undermines synergy thesis: Q2 2026 revenue of $6.913 billion grew only 0.93% year-over-year from $6.849 billion, and Q1 2026 revenue of $7.347 billion was barely above Q1 2025's $7.192 billion. Affiliate/subscription ($3.520 billion) and advertising ($1.959 billion) — the declining linear pools — still dominate the mix, while theatrical is only $138 million.
- Thin interest coverage and leverage: Debt-to-equity stands at 1.27x with a current ratio of 1.26, and Q2 2026 interest expense of $255 million against $215 million of pre-tax income implies interest coverage of roughly 1.86x. Cash fell to $1.627 billion from $1.941 billion sequentially while the company spent $2.789 billion on acquisitions in Q1 2026, leaving capital allocation dependent on external financing.
SKYD Technical Analysis
SKYD is in a clear downtrend on a one-year basis, with the stock down 14% over the trailing year (price_change of -0.14) and trading at just 8.01, near the bottom of its observed range. Against a 52-week high implied by the recent 9.53 close on 2026-10-06 and a low of 6.80 on 2026-10-19, the current price sits at roughly 44% of the 52-week range — closer to the lows than the highs, a positioning that signals persistent selling pressure rather than a healthy consolidation. The max drawdown of -28.65% confirms the stock has experienced a meaningful peak-to-trough decline, and the failure to reclaim the October highs suggests the market is treating rallies as selling opportunities rather than trend reversals.
Short-term momentum is decisively negative and diverging from an already weak longer-term trend. The stock is down 9.90% over the past month versus a 4.99% decline for the S&P 500, producing a relative strength of -4.91 — meaning SKYD has underperformed the market by nearly 5 percentage points in just four weeks. The most damaging move was the single-session gap from 9.27 on 2026-10-13 to 7.06 on 2026-10-14, a roughly 24% one-day collapse that likely reflects a negative catalyst (earnings, guidance, or a merger-related disclosure), and the stock has only recovered to 8.01 since — roughly halfway back. Volume of 11.8 million shares on the latest session indicates elevated turnover, consistent with distribution rather than accumulation.
Key technical levels are well defined: support sits at the 6.80 low from 2026-10-19, with a secondary floor near 7.06 (the post-gap close), while resistance is established at the 9.53 October high and the 9.27 pre-gap level. A breakout above 9.53 would be the first meaningful sign of trend repair and could trigger short covering, whereas a breakdown below 6.80 would confirm the downtrend and likely open the door to new lows. Beta is not available in the provided data, but the 24% single-day gap and -28.65% max drawdown imply volatility well in excess of the broad market, which argues for smaller position sizing and wider stops for anyone trading this name.
Beta
1.64
1.64x market volatility
Max Drawdown
-28.6%
Largest decline past year
52-Week Range
$7-$17
Price range past year
Annual Return
—
Cumulative gain past year
| Period | SKYD Return | S&P 500 |
|---|---|---|
| 1m | -13.8% | -2.4% |
| 3m | — | -2.3% |
| 6m | — | +2.8% |
| 1y | — | +11.3% |
| ytd | — | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SKYD Fundamental Analysis
Revenue is essentially stagnant at the top line: the most recent quarter (Q2 2026, ended 2026-06-30) delivered $6.913 billion in revenue, up just 0.93% year-over-year from $6.849 billion in Q2 2025. The multi-quarter trend shows no growth acceleration — Q1 2026 revenue of $7.347 billion was actually below Q1 2025's $7.192 billion on a comparable basis when adjusted for the merger, and Q4 2025 came in at $8.470 billion. Within the segment mix, affiliate and subscription revenue of $3.520 billion is the largest contributor, followed by advertising at $1.959 billion and licensing/other at $1.296 billion, with theatrical a minor $138 million — meaning the company's fortunes remain tied to the declining linear affiliate and advertising pools rather than a fast-growing streaming engine. The flat revenue trajectory undermines the bull case for merger synergies and suggests the combined entity is running to stand still.
Profitability is thin and erratic. Q2 2026 net income was just $41 million on $6.913 billion of revenue, a net margin of 0.59%, and gross margin collapsed to 6.87% ($475 million gross profit) from 33.9% in Q1 2026 and 32.5% in Q2 2025 — a dramatic compression that likely reflects merger-related accounting, content write-downs, or restructuring charges flowing through cost of revenue. The trailing picture is worse: trailing EPS is -$0.42, net margin is -21.2%, operating margin is -18.0%, and ROE is -52.9%, driven by the Q4 2025 loss of -$573 million (EPS -$0.52) and a catastrophic Q4 2025 EBITDA of -$6.522 billion tied to a $8.297 billion other-expense line. While Q1 2026 showed a healthier $168 million profit and 33.9% gross margin, the volatility quarter-to-quarter makes it impossible to underwrite a stable earnings base.
The balance sheet is the central risk. Debt-to-equity stands at 1.27x, the current ratio is 1.26, and interest expense of $255 million in Q2 2026 against $215 million of income before tax shows interest coverage is razor-thin (interest coverage of 1.86x in the Q2 2026 historical ratios). Free cash flow is positive but modest — $440 million TTM, with $258 million generated in Q2 2026 against $61 million of capex — and the company paid $56 million in dividends in the quarter despite the weak earnings, a payout ratio of -1.45% on negative EPS that is technically unsustainable. Cash on hand fell to $1.627 billion from $1.941 billion sequentially, and the company spent $2.789 billion on acquisitions in Q1 2026 while repaying $1.803 billion of debt, highlighting a capital allocation posture that depends on continued access to external financing rather than internally generated cash.
Quarterly Revenue
$6.9B
2026-06
Revenue YoY Growth
+0.9%
YoY Comparison
Gross Margin
6.9%
Latest Quarter
Free Cash Flow
$440000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SKYD Overvalued?
Because trailing net income is negative (EPS of -$0.42, trailing PE of -23.9x), the PE ratio is not meaningful and I am leading with the price-to-sales ratio of 0.51x as the primary metric, supplemented by the price-to-book of 1.27x. The forward PE of 0.27x is not a credible multiple — it appears to be a data artifact derived from the PEG field — but the forward EPS estimate of $0.8925 implies the Street expects a sharp swing to profitability, which at the current $8.01 price would put the stock on roughly 9.0x forward earnings. That gap between negative trailing earnings and positive forward estimates captures the entire debate: the market is pricing a turnaround that has not yet materialized.
On a peer basis, a PS ratio of 0.51x is deeply discounted versus the Communication Services sector, where large-cap media peers typically trade at 1.5x-2.5x sales. Even against SKYD's own historical PS range — which ran from 1.59x in Q2 2026 to 3.10x in Q3 2025 and 2.47x in Q2 2025 — the current 0.51x represents a roughly 68% discount to its Q2 2026 level and an 84% discount to the Q3 2025 peak. The discount is partly justified by the negative net margin of -21.2%, the -52.9% ROE, and the 1.27x debt-to-equity, but a sub-0.6x sales multiple on a $34 billion revenue base (estimated 2026 revenue of $33.9 billion) suggests the market is pricing in significant value destruction or a distressed scenario.
Historically, SKYD's valuation has compressed dramatically: PB fell from 1.73x in Q3 2025 to 1.27x in Q4 2025 to 0.94x in Q2 2026, and the current 1.27x sits in the lower third of its own range. The EV/EBITDA of -5.36x is negative and unusable due to the Q4 2025 EBITDA loss, while the price-to-free-cash-flow of 30.6x is elevated relative to the 0.51x sales multiple, reflecting the thin $440 million FCF base. Net-net, the stock is cheap on sales and book but expensive on cash flow and uninvestable on earnings — a classic value trap profile until the company demonstrates a credible path to sustained positive net income.
PE
-23.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~74x
vs. Industry Avg
25.7x
Industry PE ~25.7x*
EV/EBITDA
-5.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are acute and quantifiable. Trailing EPS of -$0.42, net margin of -21.2%, operating margin of -18.0% and ROE of -52.9% reflect a business that lost $573 million in Q4 2025 on an $8.297 billion other-expense line, and the Q2 2026 gross margin of 6.87% versus 33.9% in Q1 2026 shows earnings volatility that makes any single quarter unreliable. Interest expense of $255 million against $215 million of pre-tax income in Q2 2026 implies coverage of roughly 1.86x, and with debt-to-equity at 1.27x, cash falling to $1.627 billion from $1.941 billion, and $2.789 billion of Q1 2026 acquisition spending, the balance sheet depends on continued access to external financing. The $56 million quarterly dividend on negative EPS (payout ratio -1.45%) is technically unsustainable and would be an early casualty if cash flow deteriorates. Revenue concentration compounds the problem: affiliate/subscription ($3.520 billion) and advertising ($1.959 billion) are the largest pools and both sit in structurally declining linear categories, while theatrical contributes only $138 million. Market and competitive risks center on valuation compression and sector rotation. Even after an 84% discount to its Q3 2025 PS peak of 3.10x, the 0.51x sales multiple could compress further if the market re-rates legacy media toward distressed levels, and the -5.36x EV/EBITDA and 30.6x price-to-free-cash-flow show the stock is not cheap on cash-flow metrics despite the sales discount. Competitive disruption from streaming-native rivals pressures both the linear affiliate fees and the HBO Max/Paramount+ subscriber economics, and the thin five-analyst coverage on a $14.8 billion market cap implies limited institutional sponsorship and inefficient price discovery — consistent with the roughly 24% single-day gap on 2026-10-14. Beta is not disclosed, but the -28.65% max drawdown and 24% gap imply volatility well above the broad market, and the stock's -9.90% one-month move against a -4.99% S&P 500 decline (relative strength -4.91) shows it is being sold harder than the sector. The worst-case scenario is a chain in which Q3/Q4 2026 results confirm the 6.87% gross margin is structural rather than transitional, the $0.8925 forward EPS consensus is cut, and rating agencies or lenders force a dividend suspension or equity raise to protect the 1.27x debt-to-equity balance sheet. In that path the stock would retest and likely break its 6.80 low of 2026-10-19, opening the door to new lows; from the current $8.01 that is a decline of roughly 15% to the 52-week low, and a move toward the -28.65% max-drawdown magnitude from current levels would imply a price near $5.70, a loss of approximately 29%. A more severe distressed re-rating toward 0.3x sales would be materially worse, so position sizing should assume at least a 30% downside case.
FAQ
The most severe risk is that the Q2 2026 gross-margin collapse to 6.87% — down from 33.9% in Q1 2026 and 32.5% in Q2 2025 — proves structural rather than a merger-accounting artifact, which would invalidate the $0.8925 consensus EPS and force consensus cuts. Second is balance-sheet stress: debt-to-equity of 1.27x, interest expense of $255 million against $215 million of pre-tax income (roughly 1.86x coverage), cash down to $1.627 billion from $1.941 billion, and a $56 million quarterly dividend on a -1.45% payout ratio that could be suspended or replaced by dilutive equity issuance. Third is structural revenue erosion: revenue grew only 0.93% year-over-year to $6.913 billion, and the two largest pools — affiliate/subscription at $3.520 billion and advertising at $1.959 billion — sit in declining linear categories exposed to cord-cutting. Fourth is market and sentiment risk: the stock fell 9.90% in a month versus a 4.99% S&P 500 decline (relative strength -4.91), gapped roughly 24% in a single session on 2026-10-14, has a -28.65% max drawdown, and is covered by only five analysts, four of whom are at Sell/Underweight — thin sponsorship that amplifies volatility.
The 12-month view is split three ways: a 50% base case of $7.50–$9.50, a 25% bull case of $11.50–$13.00, and a 25% bear case of $5.50–$6.80. The base case assumes the stock grinds sideways between the 6.80 October low and the 9.53 October high while the market waits for proof of margin recovery, with earnings landing between the $168 million Q1 2026 profit and the $41 million Q2 2026 figure. The bull case requires gross margin to normalize back toward 33.9% and the company to post the $0.8925 consensus EPS, which would validate roughly 9.0x forward earnings and support a re-rating toward 1.0x–1.2x sales on a $33.9 billion revenue base. The bear case assumes 6.87% margin proves structural, consensus EPS is cut, and the balance sheet forces a dividend suspension or equity raise, retesting and breaking 6.80 with a move matching the -28.65% max drawdown implying roughly $5.70. The base case is most likely, and its key assumption is that free cash flow holds near $440 million TTM while margins only partially recover.
On sales and book SKYD looks undervalued; on cash flow and earnings it looks expensive or uninvestable, which is the definition of a potential value trap. The 0.51x price-to-sales is roughly a 68% discount to its own Q2 2026 reading of 1.59x and an 84% discount to the 3.10x Q3 2025 peak, and 1.27x price-to-book sits in the lower third of its historical range (1.73x in Q3 2025, 0.94x in Q2 2026). But the trailing PE of -23.9x is meaningless on -$0.42 EPS, EV/EBITDA of -5.36x is unusable because of the Q4 2025 EBITDA loss, and 30.6x price-to-free-cash-flow is not cheap for a business with a -21.2% net margin. The market is effectively pricing a distressed scenario — sub-0.6x sales on a $33.9 billion estimated 2026 revenue base implies expectations of continued value destruction. If the Street's $0.8925 EPS materializes, the stock is on roughly 9.0x forward earnings and is cheap; if that estimate is cut, the sales discount is deserved.
It is a good buy only for investors with a high risk tolerance and a value/special-situations mandate, and only as a sized-down position. The reward case is real: 0.51x sales versus a 1.59x–3.10x historical PS range, 1.27x book, and roughly 9.0x the $0.8925 consensus 2026 EPS if the company swings from -$0.42 trailing EPS to profitability, with $440 million of TTM free cash flow underpinning the story. The downside is equally concrete: gross margin fell to 6.87% in Q2 2026 from 33.9% in Q1 2026, revenue grew just 0.93% year-over-year, and interest coverage of roughly 1.86x leaves little room for error. The stock has already bounced about 18% off the 6.80 low to $8.01, so much of the immediate oversold relief may be spent, and four brokers (UBS, Barclays, Wells Fargo, Bernstein) remain at Sell/Underweight. A reasonable approach is a small starter position with a hard stop below 6.80, adding only on a clean quarter showing gross margin back above 30% with positive net income.
SKYD is better suited to a medium-term, catalyst-driven holding than to either pure day-trading or a multi-decade buy-and-hold. The stock is in a confirmed downtrend — down 14% over the trailing year, 9.90% in the past month versus a 4.99% S&P 500 decline, with a -28.65% max drawdown and a roughly 24% single-day gap on 2026-10-14 — so short-term trading demands tight stops and small size given the volatility implied by that gap. On the other side, the dividend yield of just 0.61% on a -1.45% payout ratio means there is no income cushion to reward passive long-term holding, and earnings visibility is poor with quarterly EPS swinging from $0.15 in Q1 2026 to $0.04 in Q2 2026 to -$0.52 in Q4 2025. A sensible minimum holding period is 12–18 months, long enough to see two to three quarters of margin evidence and any merger-synergy realization, with the position reassessed after each print. The practical framework is to hold through the next two earnings reports and exit on a close below 6.80 or on any cut to the 2026 EPS consensus.